Continuus Pharmaceuticals, a spinout from the Massachusetts Institute of Technology that planned to build a new manufacturing facility in Woburn, Massachusetts, canceled its construction contract for the project valued at $112 million. The cancellation was announced by the global construction firm Skanska, which had been selected to build the new complex.